The Nigeria Centre for Disease Control (NCDC) don yarn say dem never approve the new COVID-19 drug, Dexamethasone  for use in the treatment of patients with the  disease for Naija.

The drug, wey scientists for the United Kingdom don hail as a major breakthrough, na widely used low-dose steroid wey dem find to considerably reduce the risk of patients wey dey die from COVID-19.

The NCDC for plenty of Tweets posted on Tuesday night, June 16 say dem dey aware of the drug.

Make Una read wetin dem yarn

“The Nigeria Centre for Disease Control (NCDC) is aware of recent outcomes from a UK-Government funded clinical trial for COVID-19. The results support the use of Dexamethasone as a possible treatment to reduce the risk of death among COVID-19 patients, who require oxygen or mechanical ventilation.

Please note that the Government of Nigeria has not validated or approved any treatment for COVID-19. In addition, the use of Dexamethasone for COVID-19 treatment has not been validated by WHO.

We are aware of ongoing clinical trials conducted by scientists in the UK and will work with our sister agencies to evaluate this emerging data on the use of Dexamethasone. We will inform the general public on outcomes following scientific review and validation.”.